Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pancreatic toxicity preclinical evaluation

It is currently well known that there is a lack of sensitive and specific pancreatic biomarkers available for use in drug development research. This is especially true in the preclin-ical setting, because these biomarkers are not routinely evaluated and prechnical pancreatic toxicity occurs infrequently. While exploratory biomarkers such as TLI, PLI, and TAP have been sporadically tested, there is great value in investing in the development of rehable reagents across... [Pg.253]

See other pages where Pancreatic toxicity preclinical evaluation is mentioned: [Pg.242]    [Pg.245]    [Pg.245]    [Pg.245]    [Pg.246]    [Pg.247]    [Pg.672]    [Pg.358]   
See also in sourсe #XX -- [ Pg.245 , Pg.246 , Pg.247 , Pg.248 , Pg.253 , Pg.254 , Pg.255 , Pg.256 ]



SEARCH



Pancreatic toxicity

Preclinical

Preclinical toxicity

Toxicity, evaluation

© 2024 chempedia.info